Tag: Chemotherapy
High Response Seen for Chemo in Seniors With High-Risk AML
Complete response rate for patients treated with chemo was 69 percent; three-year OS was 21 percent
Chemoradiation Does Not Up Survival in Endometrial Cancer
Distant recurrence more common with chemoradiation versus chemotherapy in stage III, IVA disease
Chemoimmunotherapy Regimen Approved to Treat DLBCL
Polivy approved in combination with bendamustine, rituximab for diffuse large B-cell lymphoma
ASCO: Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer
Elderly, frail receiving 60 percent of oxaliplatin/capecitabine dose have noninferior PFS, less toxicity
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer
For patients with PD-L1 combined positive score of ≥10, pembrolizumab prolongs overall survival
Octogenarians With Acute Myeloid Leukemia Have Poor Survival
Overall survival 1.5 months; survival improved for those receiving chemotherapy
Fifteen Million Patients Will Need First-Course Chemo in 2040
Number of cancer physicians required to deliver optimal chemo set to increase to 100,000 by 2040
Test Predicts Benefit of Chemo in ER+, HER2− Breast Cancer
EndoPredict, a multigene test, helps predict whether adjuvant chemotherapy would be beneficial
New Lesions ID’d on Breast MRI During Treatment Likely Benign
New suspicious lesions detected on breast MRI during neoadjuvant therapy are more likely benign
Sucking Ice Chips Cuts Oral Side Effects of Oxaliplatin Chemo
Benefits include less trouble eating and fewer symptom-related negative effects on quality of life
